Division of Hematology and Hematologic Malignancies, Department of Internal Medicine, University of Utah, Salt Lake City, UT.
Hematology Division, Department of Medicine, Brigham and Women's Hospital, Boston, MA.
Hematology Am Soc Hematol Educ Program. 2021 Dec 10;2021(1):529-535. doi: 10.1182/hematology.2021000288.
With improvements in medical care, the life expectancy of patients with bleeding disorders is approaching that of the general population. A growing population of older adult patients with bleeding disorders is at risk of age-related comorbidities and in need of various elective and emergent age-related procedures. The increased risk of thrombosis and volume overload in older adults complicates perioperative hemostatic management. Furthermore, antithrombotic treatment such as antiplatelet or anticoagulant therapy, which is frequently required for various cardiovascular interventions, requires a meticulous individualized approach. Evidence-based guidelines for the management of aging patients with bleeding disorders are lacking, largely due to the underrepresentation of older adult patients in clinical trials as well as the rarity of many such bleeding disorders. We discuss the current guidelines and recommendations in the perioperative hemostatic management of older adult patients with hemophilia and von Willebrand disease as well as other rare bleeding disorders. The optimal management of these patients is often complex and requires a thorough multidisciplinary and individualized approach involving hematologists, surgeons, anesthesiologists, and the specialists treating the underlying disorder.
随着医疗水平的提高,出血性疾病患者的预期寿命已接近普通人群。越来越多的老年出血性疾病患者面临与年龄相关的合并症风险,需要进行各种择期和紧急与年龄相关的手术。老年人血栓形成和血容量过多的风险增加,使围手术期止血管理变得复杂。此外,抗血小板或抗凝治疗等抗血栓治疗,常用于各种心血管介入治疗,需要精心制定个体化方案。缺乏针对出血性疾病老年患者管理的循证指南,主要是由于临床试验中老年人患者代表性不足,以及许多此类出血性疾病罕见。我们讨论了在围手术期对血友病和血管性血友病以及其他罕见出血性疾病老年患者进行止血管理的现行指南和建议。这些患者的最佳管理通常很复杂,需要涉及血液科医生、外科医生、麻醉师以及治疗潜在疾病的专家的全面多学科和个体化方法。